Next, through the survival analysis, we revealed that high HNRNPC expression in 30 tumor tissues predicted a poor prognosis for NSCLC patients (P < 0.05) (Fig. 3F). The gene discussed is HNRNPC; the disease is non-small cell lung carcinoma.